NGAL
Lipocalin-2 (LCN2), also known as oncogene 24p3 or neutrophil gelatinase-associated lipocalin (NGAL), is a protein that in humans is encoded by the LCN2 gene. NGAL is involved in innate immunity by sequestering iron and preventing its use by bacteria, thus limiting their growth. It is expressed in neutrophils and in low levels in the kidney, prostate, and epithelia of the respiratory and alimentary tracts. NGAL is used as a biomarker of kidney injury.
Beyond's analysis on NGAL
Recent news mentioning NGAL
- — First Patient In - BioPorto Initiates Patient Enrollment as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
- — Første patient indrulleret - BioPorto har påbegyndt indrullering som en del af ProNephro AKI® U.S. Adult Urine NGAL validerings studiet.
- — TTM Technologies, Inc. to Exhibit at electronica India 2026 Trade Fair in Bangalore, Showcasing Leading Advanced Interconnect Solutions and Integrated Systems
- — Mesirow's Gary Pattengale Discusses Year-End Tax Planning Strategies on WGN Radio
- — Teradyne India Office Expands Semiconductor Manufacturing Support in Bengaluru
- — Nightingale Ice Cream Sandwiches® and National Park Foundation Bring Campfire Nostalgia to the Freezer Aisle with New S'mores Ice Cream Sandwich
- — Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
- — Cloudphysician Unveils Nightingale, a Visual Intelligence Foundation Model Built for the Hospital Room
- — Flipkart begins internal food delivery pilot in Bengaluru, India
- — Are Wall Street Analysts Bullish on Huntington Ingalls Stock?
- — Bioforum The Data Masters Expands Global Footprint with New Office and Global Capability Center in Bangalore, India
- — Tenjumps Expands into Bangalore to Support Growing Global Demand